Basic Information
Duaklir Genuair
Regulatory Information
EMEA/H/C/003745
November 19, 2014
September 25, 2014
16
February 26, 2025
Company Information
the netherlands
Gustav Mahlerplein 2 1082 MA Amsterdam
Covis Pharma Europe BV
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Duaklir Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Overview Summary
This is a summary of the European public assessment report (EPAR) for Duaklir Genuair. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Duaklir Genuair. For practical information about using Duaklir Genuair, patients should read the package leaflet or contact their doctor or pharmacist.